Tower Research Capital (TRC)’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.6K | Buy |
21,581
+10,827
| +101% | +$7.85K | ﹤0.01% | 3805 |
|
2025
Q1 | $9.26K | Sell |
10,754
-2,477
| -19% | -$2.13K | ﹤0.01% | 3802 |
|
2024
Q4 | $22.2K | Buy |
13,231
+9,699
| +275% | +$16.3K | ﹤0.01% | 3105 |
|
2024
Q3 | $10.1K | Sell |
3,532
-6,806
| -66% | -$19.4K | ﹤0.01% | 3807 |
|
2024
Q2 | $24.2K | Buy |
10,338
+6,432
| +165% | +$15.1K | ﹤0.01% | 3652 |
|
2024
Q1 | $11.5K | Sell |
3,906
-691
| -15% | -$2.03K | ﹤0.01% | 3559 |
|
2023
Q4 | $13.7K | Buy |
4,597
+89
| +2% | +$266 | ﹤0.01% | 3938 |
|
2023
Q3 | $14.2K | Buy |
4,508
+2,291
| +103% | +$7.24K | ﹤0.01% | 3700 |
|
2023
Q2 | $8.58K | Sell |
2,217
-2,516
| -53% | -$9.74K | ﹤0.01% | 4385 |
|
2023
Q1 | $13K | Sell |
4,733
-1,079
| -19% | -$2.96K | ﹤0.01% | 3988 |
|
2022
Q4 | $10K | Sell |
5,812
-423
| -7% | -$728 | ﹤0.01% | 4037 |
|
2022
Q3 | $13K | Sell |
6,235
-13,251
| -68% | -$27.6K | ﹤0.01% | 4275 |
|
2022
Q2 | $52K | Buy |
19,486
+17,066
| +705% | +$45.5K | ﹤0.01% | 2842 |
|
2022
Q1 | $11K | Sell |
2,420
-150
| -6% | -$682 | ﹤0.01% | 4192 |
|
2021
Q4 | $14K | Buy |
2,570
+1,570
| +157% | +$8.55K | ﹤0.01% | 4089 |
|
2021
Q3 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 4766 |
|
2021
Q2 | – | Sell |
-15
| Closed | – | – | 5711 |
|
2021
Q1 | $0 | Buy |
+15
| New | – | ﹤0.01% | 5602 |
|